Ariad Pharmaceuticals Inc fka ARIA

[gr8db8]

@2damoon1 I agree that "The market turned on Ariad". Yes ... after Gleevec, Sprycel and Tasigna .. or Bosulif .. or T315i mutation .. Pona is seen as the last resort. The negative results/press was a kiss of death. Folks avoid it even and are scared to take it even when all other options run out and even when they're staring off at 15 mg.

Certainly, Ariad has its work cut out going forward to improve Pona's perception/image ...

But information is now slowly coming out (from patients that have used G, S and/or T) that Pona is effective (very effective) for some patients that have no/little other option. Thus, the lower scripts #s are not surprising.